Full-year 2025 preliminary1 U.S. net product revenues of $689 millionSYFOVRE® (pegcetacoplan injection) total injection demand grew 17% ...
Clinical trials have shown that the pill can deliver comparable weight-loss results to the injectable form when used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback